content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Cesca Therapeutics, Inc (KOOL)
0.00
(0.00%)
content_middle
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.
Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.
Previous Close:
0.00
Open:
3.31
Bid:
3.35
Ask:
3.40
1yr Target Price:
2.00
Day's Range:
3.16 - 3.34
52wk Range:
0.00 - 0.00
Volume:
7977
Average Daily Volume:
92565
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- October 29, 2014 - 10:09am | BOD & C-Suite Updates
- October 28, 2014 - 9:06am | BOD & C-Suite Updates
- October 16, 2014 - 2:13pm | Earnings Q3
- October 13, 2014 - 10:16am | Out and About
- October 9, 2014 - 1:11pm | Earnings
- September 29, 2014 - 10:34am | Earnings
- September 29, 2014 - 10:10am | IP & Patents
- September 10, 2014 - 9:05am | IP & Patents
- September 8, 2014 - 3:18pm | Model Portfolio
- September 4, 2014 - 9:04am | BOD & C-Suite Updates
- August 10, 2014 - 12:50pm | Clear and Present Dangers
- August 3, 2014 - 10:30pm | Earnings Q2
- July 8, 2014 - 11:06am | Out and About, Regulatory
- June 12, 2014 - 4:59pm | Financings
- June 10, 2014 - 9:53am | Out and About, Research Notes
- May 22, 2014 - 10:42am | Out and About
- May 17, 2014 - 1:31pm | Earnings, Earnings Q1
- May 17, 2014 - 1:27pm | Earnings
- May 12, 2014 - 9:56am | BOD & C-Suite Updates
- March 26, 2014 - 11:02am | Research Notes